Genzyme’s MS drug approved in Mexico, but still no word on U.S. appeal

While there is still no news from drug giant Genzyme Corp. about its appeal of the rejection by U.S. regulators of its multiple sclerosis drug, Lemtrada, the company can now add one more country to the list of those that have approved it...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.